BRPI0410283A - métodos de análise de uma região de ácido nucleico marcadora, de detecção ou monitoração de uma população clonal de células em um mamìfero, de diagnóstico e/ou de monitoração de uma condição de doença de mamìfero e de enriquecimento de uma população de moléculas de ácido nucleico em uma amostra biológica - Google Patents

métodos de análise de uma região de ácido nucleico marcadora, de detecção ou monitoração de uma população clonal de células em um mamìfero, de diagnóstico e/ou de monitoração de uma condição de doença de mamìfero e de enriquecimento de uma população de moléculas de ácido nucleico em uma amostra biológica

Info

Publication number
BRPI0410283A
BRPI0410283A BRPI0410283-5A BRPI0410283A BRPI0410283A BR PI0410283 A BRPI0410283 A BR PI0410283A BR PI0410283 A BRPI0410283 A BR PI0410283A BR PI0410283 A BRPI0410283 A BR PI0410283A
Authority
BR
Brazil
Prior art keywords
nucleic acid
monitoring
acid region
population
analyzing
Prior art date
Application number
BRPI0410283-5A
Other languages
English (en)
Inventor
Alexander Alan Morley
Michael Brisco
Pamela Sykes
Original Assignee
Monoquant Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monoquant Pty Ltd filed Critical Monoquant Pty Ltd
Publication of BRPI0410283A publication Critical patent/BRPI0410283A/pt
Publication of BRPI0410283B1 publication Critical patent/BRPI0410283B1/pt
Publication of BRPI0410283B8 publication Critical patent/BRPI0410283B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"MéTODOS DE ANáLISE DE UMA REGIãO DE áCIDO NUCLEICO MARCADORA, DE DETECçãO OU MONITORAçãO DE UMA POPULAçãO CLONAL DE CéLULAS EM UM MAMìFERO, DE DIAGNóSTICO E/OU DE MONITORAçãO DE UMA CONDIçãO DE DOENçA DE MAMìFERO E DE ENRIQUECIMENTO DE UMA POPULAçãO DE MOLéCULAS DE áCIDO NUCLEICO EM UMA AMOSTRA BIOLóGICA". A presente invenção refere-se a um método de caracterização de uma região de ácido nucleico e, mais particularmente, a um método de análise de uma região de ácido nucleico marcadora. O método da presente invenção baseia-se na identificação de uma ou de ambas as regiões de ácido nucleico flanqueando uma região de ácido nucleico marcadora e proporciona um meio de análise de uma região de ácido nucleico marcadora que é característica de uma população clonal de células. O método da presente invenção é útil no contexto de permitir uma variedade de aplicações incluindo, mas não limitadas a, monitoração da progressão de uma condição caracterizada pela presença de uma população clonal de células (tais como condições neoplásicas), monitoração dos níveis de uma ou mais populações clonais de células, predição da possibilidade de uma reincidência de um indivíduo de um estado remissivo para um estado doentio, para avaliar a efetividade de drogas terapêuticas existentes e/ou agentes terapêuticos novos e identificação da presença de uma região marcadora.
BRPI0410283A 2003-05-13 2004-05-13 método de caracterização de um gene de região variável de receptor de células t ou imunoglobulina rearranjado BRPI0410283B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003902299A AU2003902299A0 (en) 2003-05-13 2003-05-13 A method of analysing a marker nucleic acid molecule
AU2003902299 2003-05-13
PCT/AU2004/000625 WO2004101815A1 (en) 2003-05-13 2004-05-13 Identification of clonal cells by repeats in (eg.) t-cell receptor v/d/j genes

Publications (3)

Publication Number Publication Date
BRPI0410283A true BRPI0410283A (pt) 2006-05-16
BRPI0410283B1 BRPI0410283B1 (pt) 2018-02-06
BRPI0410283B8 BRPI0410283B8 (pt) 2021-07-27

Family

ID=31501168

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410283A BRPI0410283B8 (pt) 2003-05-13 2004-05-13 método de caracterização de um gene de região variável de receptor de células t ou imunoglobulina rearranjado

Country Status (9)

Country Link
US (1) US7785783B2 (pt)
EP (1) EP1633884B1 (pt)
JP (3) JP2007515154A (pt)
KR (2) KR101215194B1 (pt)
CN (1) CN1806051B (pt)
AU (3) AU2003902299A0 (pt)
BR (1) BRPI0410283B8 (pt)
CA (1) CA2525122C (pt)
WO (1) WO2004101815A1 (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200700942A1 (ru) * 2007-04-06 2007-12-28 Петр Генриевич ЛОХОВ Способ определения качества клеточной культуры
ES2331499B1 (es) * 2007-08-02 2010-10-14 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud En Sevilla (Fund.Sevilla) Cebadores, procedimiento y conjunto de utiles para la determinacion d e la funcionalidad del timo humano.
GB2477439B (en) 2008-11-07 2012-02-15 Sequenta Inc Methods for correlating clonotypes with a disease in a patient
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
ES2568509T3 (es) 2009-01-15 2016-04-29 Adaptive Biotechnologies Corporation Perfilado de la inmunidad adaptativa y métodos para la generación de anticuerpos monoclonales
RU2014144463A (ru) 2009-06-25 2015-06-20 Фред Хатчинсон Кансэр Рисёч Сентер Способ измерения адаптивного иммунитета
CN103097888B (zh) 2010-05-06 2016-03-09 赛昆塔有限责任公司 利用克隆型谱监测健康和疾病状态
EP2566984B1 (en) 2010-05-07 2019-04-03 The Board of Trustees of the Leland Stanford Junior University Measurement and comparison of immune diversity by high-throughput sequencing
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
US9279159B2 (en) 2011-10-21 2016-03-08 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
ES2683037T3 (es) 2011-12-09 2018-09-24 Adaptive Biotechnologies Corporation Diagnóstico de tumores malignos linfoides y detección de enfermedad residual mínima
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
DK2823060T3 (en) 2012-03-05 2018-05-28 Adaptive Biotechnologies Corp Determination of associated immune receptor chains from frequency-matched subunits
US9150905B2 (en) 2012-05-08 2015-10-06 Adaptive Biotechnologies Corporation Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions
CN105189779B (zh) 2012-10-01 2018-05-11 适应生物技术公司 通过适应性免疫受体多样性和克隆性表征进行的免疫能力评估
WO2015160439A2 (en) 2014-04-17 2015-10-22 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
US9128861B2 (en) 2013-01-17 2015-09-08 Personalis, Inc. Methods and systems for genetic analysis
WO2014121272A2 (en) 2013-02-04 2014-08-07 Quake Stephen R Measurement and comparison of immune diversity by high-throughput sequencing
GB2525568B (en) 2013-03-15 2020-10-14 Abvitro Llc Single cell barcoding for antibody discovery
EP3415626B1 (en) 2013-03-15 2020-01-22 Lineage Biosciences, Inc. Methods and compositions for tagging and analyzing samples
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
WO2015031689A1 (en) 2013-08-30 2015-03-05 Personalis, Inc. Methods and systems for genomic analysis
WO2015051275A1 (en) 2013-10-03 2015-04-09 Personalis, Inc. Methods for analyzing genotypes
US11203783B2 (en) 2013-11-21 2021-12-21 Repertoire Genesis Incorporation T cell receptor and B cell receptor repertoire analysis system, and use of same in treatment and diagnosis
AU2015227054A1 (en) 2014-03-05 2016-09-22 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
MX2017003382A (es) 2014-09-15 2017-11-20 Abvitro Llc Secuenciacion de bibliotecas de nucleotidos de alto rendimiento.
AU2015339191A1 (en) 2014-10-29 2017-05-18 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
EP3212808B1 (en) 2014-10-30 2022-03-02 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
EP3018214B1 (en) 2014-11-05 2017-12-13 Fundacion de Investigacion Hospital 12 de Octubre Method for quantifying the level of minimal residual disease in a subject
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
WO2016086029A1 (en) 2014-11-25 2016-06-02 Adaptive Biotechnologies Corporation Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
AU2016222788B2 (en) 2015-02-24 2022-03-31 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
EP3277294B1 (en) 2015-04-01 2024-05-15 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
US10920273B2 (en) 2017-01-17 2021-02-16 Life Technologies Corporation Compositions and methods for immune repertoire sequencing
US11008609B2 (en) 2017-09-01 2021-05-18 Life Technologies Corporation Compositions and methods for immune repertoire sequencing
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
EP3802870A4 (en) * 2018-06-11 2022-03-23 Monoquant PTY LTD AMPLIFICATION METHOD AND PRIMER THEREFOR
CN110656161B (zh) * 2018-06-28 2022-12-13 苏州云泰生物医药科技有限公司 用于检测人免疫球蛋白基因重排的毛细管电泳试剂盒及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296351A (en) * 1988-10-20 1994-03-22 Alexander A. Morley Method for diagnosis of monoclonality in leukaemia and lymphoma
GB9507238D0 (en) * 1995-04-07 1995-05-31 Isis Innovation Detecting dna sequence variations
US6238863B1 (en) * 1998-02-04 2001-05-29 Promega Corporation Materials and methods for indentifying and analyzing intermediate tandem repeat DNA markers
CN1264744A (zh) * 1999-02-26 2000-08-30 上海生元基因开发有限公司 一种通过循环差减进行大规模cDNA克隆和测序的方法
AUPQ687600A0 (en) 2000-04-13 2000-05-11 Flinders Technologies Pty Ltd A method of detection
AU2000269239A1 (en) * 2000-08-22 2002-03-04 Baylor College Of Medicine T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection
CN1965089A (zh) * 2002-10-11 2007-05-16 鹿特丹伊拉兹马斯大学 用于基于pcr的克隆系研究的核酸扩增引物

Also Published As

Publication number Publication date
EP1633884A1 (en) 2006-03-15
JP6189600B2 (ja) 2017-08-30
KR20060015604A (ko) 2006-02-17
AU2009238365A1 (en) 2009-12-10
EP1633884B1 (en) 2014-06-25
EP1633884A4 (en) 2008-03-05
JP2016027825A (ja) 2016-02-25
BRPI0410283B8 (pt) 2021-07-27
JP2007515154A (ja) 2007-06-14
AU2003902299A0 (en) 2003-05-29
AU2004238887A1 (en) 2004-11-25
BRPI0410283B1 (pt) 2018-02-06
CA2525122A1 (en) 2004-11-25
US20050255482A1 (en) 2005-11-17
CA2525122C (en) 2015-11-24
CN1806051B (zh) 2012-05-30
JP2013116116A (ja) 2013-06-13
CN1806051A (zh) 2006-07-19
KR20120107521A (ko) 2012-10-02
WO2004101815A1 (en) 2004-11-25
US7785783B2 (en) 2010-08-31
KR101215194B1 (ko) 2012-12-24

Similar Documents

Publication Publication Date Title
BRPI0410283A (pt) métodos de análise de uma região de ácido nucleico marcadora, de detecção ou monitoração de uma população clonal de células em um mamìfero, de diagnóstico e/ou de monitoração de uma condição de doença de mamìfero e de enriquecimento de uma população de moléculas de ácido nucleico em uma amostra biológica
Zhu et al. Single-neuron identification of chemical constituents, physiological changes, and metabolism using mass spectrometry
Collins et al. High throughput toxicity screening and intracellular detection of nanomaterials
Dusinska et al. The comet assay in human biomonitoring: gene–environment interactions
Farmer et al. Molecular epidemiology studies of carcinogenic environmental pollutants: effects of polycyclic aromatic hydrocarbons (PAHs) in environmental pollution on exogenous and oxidative DNA damage
Ladeira et al. Human biomonitoring: An overview on biomarkers and their application in occupational and environmental health
Gouzerh et al. Odors and cancer: Current status and future directions
Anderson et al. The comet assay in human biomonitoring
GB0524110D0 (en) Biomarkers and methods for identification of agents useful in the treatment of affective disorders
Reilly et al. Bio-collections in autism research
Calini et al. Comet assay evaluation of DNA single-and double-strand breaks induction and repair in C3H10T1/2 cells
Bhattacharya et al. Biomarkers in risk assessment of asbestos exposure
Iwakawa et al. DNA repair capacity measured by high throughput alkaline comet assays in EBV-transformed cell lines and peripheral blood cells from cancer patients and healthy volunteers
Yoshioka et al. Fluorescence laser microdissection reveals a distinct pattern of gene activation in the mouse hippocampal region
KR101138343B1 (ko) 알츠하이머 질병의 진단을 위한 신속한 시험법
Barle et al. The value of acute toxicity testing of pharmaceuticals for estimation of human response
Anderson et al. The comet assay in human biomonitoring
Sutter Molecular and cellular approaches to extrapolation for risk assessment.
Ferreira et al. Using the alternative model C. elegans in reproductive and developmental toxicology studies
BR112012029520A2 (pt) instrumento de diagnóstico e processo de fluxo.
Pulczinski et al. DNA hydroxymethylation: implications for toxicology and epigenetic epidemiology
Ancizar-Aristizábal et al. Approaches and perspectives to toxicogenetics and toxicogenomics
Au et al. Biomarkers in population studies: environmental mutagenesis and risk for cancer
KR20030009531A (ko) 중간엽 줄기 세포를 사용하는 독성 타이핑
CN102495214B (zh) 鞘脂激活蛋白原作为效应标志物在检测多氯联苯雄性生殖毒性的应用

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/05/2004, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO